Dietary Advanced Glycation End Products and Cardiometabolic Risk (Q39427655)

11 September 2017

Dietary Advanced Glycation End Products and Cardiometabolic Risk (English)

1 reference

11 September 2017

Claudia Luévano-Contreras

1

1 reference

11 September 2017

Armando Gómez-Ojeda

2

1 reference

11 September 2017

Maciste Habacuc Macías-Cervantes

3

1 reference

11 September 2017

Ma Eugenia Garay-Sevilla

4

1 reference

11 September 2017

1 August 2017

1 reference

11 September 2017

Current diabetes report

1 reference

11 September 2017

17

1 reference

11 September 2017

63

1 reference

11 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-017-0891-2

11 September 2017

0 references

cites work

Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Cardiovascular Disease Risk Assessment: Insights from Framingham

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Cardiovascular risk factors. Insights from Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Definition and current situation of cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products in foods and a practical guide to their reduction in the diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary advanced glycation end products and their role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Role of advanced glycation end products in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation endproducts in food and their effects on health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Role of advanced glycation end products in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Protein glycation during aging and in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation End-products (AGEs): an emerging concern for processed food industries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Receptor for advanced glycation end products and its involvement in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced Glycation End Product Recognition by the Receptor for AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Baking, ageing, diabetes: a short history of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Historical perspective of the Maillard reaction in food science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Nutritional and toxicological aspects of the Maillard browning reaction in foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Comment on "Advanced glycation endproducts in food and their effects on health" by Poulsen et al. (2013) Food and Chemical Toxicology 60, 10-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Forty years of furosine - forty years of using Maillard reaction products as indicators of the nutritional quality of foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effect of cooking method on carnosine and its homologues, pentosidine and thiobarbituric acid-reactive substance contents in beef and turkey meat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

N-ε-fructosyllysine and N-ε-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Renal catabolism of advanced glycation end products: the fate of pentosidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effects of Long-Term Exposure to Free Nε-(Carboxymethyl)lysine on Rats Fed a High-Fat Diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

RAGE-mediated MAPK activation by food-derived AGE and non-AGE products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Short-term effects of dietary advanced glycation end products in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Advanced glycation end products are direct modulators of β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary consumption of advanced glycation end products and risk of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Glycoxidation and inflammation in renal failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effect of recreational physical activity on insulin levels in Mexican/Hispanic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0891-2

A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases

21 January 2018

1 reference

12 December 2020

[Aerobic 12-week training reduces cardiovascular risk factors in overweight teenagers]

1 reference

12 December 2020

Quantitative assessment of organ distribution of dietary protein-bound (13) C-labeled N(ɛ) -carboxymethyllysine after a chronic oral exposure in mice

1 reference

12 December 2020

Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy

1 reference

12 December 2020

Effect of Tai Chi exercise on DNA damage, antioxidant enzymes, and oxidative stress in middle-age adults

1 reference

12 December 2020

Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

12 December 2020

Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration

1 reference

12 December 2020

Targeted reduction of advanced glycation improves renal function in obesity

1 reference

12 December 2020

Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway

1 reference

12 December 2020

The Legacy of Dr. Ralph Seal Paffenbarger, Jr. - Past, Present, and Future Contributions to Physical Activity Research

1 reference

12 December 2020

Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs

1 reference

12 December 2020

Study of the urinary and faecal excretion of Nε-carboxymethyllysine in young human volunteers

1 reference

12 December 2020

Transport of free and peptide-bound glycated amino acids: synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins

1 reference

12 December 2020

An advanced glycation end product (AGE)-rich diet promotes Nε-carboxymethyl-lysine accumulation in the cardiac tissue and tendons of rats

1 reference

12 December 2020

AGEs in foods: Do they play a role in uremia?

1 reference

12 December 2020

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

12 December 2020

Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects

1 reference

12 December 2020

Decrease in serum levels of advanced glycation end-products by short-term lifestyle modification in non-diabetic middle-aged females.

1 reference

12 December 2020

10.1007/S11892-017-0891-2

Identifiers

DOI

1 reference

11 September 2017

1 reference